Produced in collaboration with Bladder Cancer Advocacy Network (BCAN)
This patient education activity is supported by educational grants from Merck; Astellas and Seagen Inc.; and UroGen Pharma, Inc.
Learn how you can take control of bladder cancer by improving communication with your healthcare team and becoming more involved in decision-making. Find out how knowing the different bladder-cancer types, their surgical and non-surgical treatment options, and rehabilitation strategies can lead to a better quality of life for you.
Neal Shore, MD, the National Urology Research Director at GenesisCare and an expert in systemic therapies for patients with advanced urologic cancers, moderates a new interactive video session, “Taking Control of Bladder Cancer Management.” Get an overview of bladder cancer as a disease state, practical aspects of treatment, and best practices for maintaining quality of life Register now to watch on-demand.
After watching this program, you will know more about:
- Different types of bladder cancer and how type of cancer impacts who is on the healthcare team
- Surgical and non-surgical treatment options for bladder cancer
- Best practices to maintain quality of life while undergoing therapy and monitoring for disease recurrence
Come back in October for an additional on-demand activity, “Patient Perspectives on Kidney-Sparing Approaches for UTUC,” which will review a collection of real-world data and patient interviews about their experiences with kidney-sparing approaches for upper-tract urothelial carcinoma (UTUC). Expert faculty will discuss strategies to improve care based on the evidence and patient insights.
Neal Shore, MD, FACS
Director, CPI, Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, South Carolina
Neal D. Shore, MD, FACS, is the medical director for the Carolina Urologic Research Center and practices with Atlantic Urology Clinics in Myrtle Beach, South Carolina. Dr Shore has conducted more than 350 clinical trials that focus mainly on GU oncology, has served on the executive boards of the Society of Urologic Oncology, Bladder Cancer Advocacy Network and the Society of Urologic Oncology Clinical Trials Consortium, and is immediate past president of the Large Urology Group Practice Association. He is a founder for the CUSP Clinical Trials Consortium and DASHKO, large urology practices data registries. He has over 150 peer-reviewed publications, several book chapters, and is a peer reviewer for numerous high-impact medical journals. He earned his MD from Duke University Medical School and general surgery/urology residency at New York Hospital-Cornell and Memorial Sloan Kettering Cancer Center.
Director of Education & Advocacy Bladder Cancer Advocacy Network
Interview Participant, Patient Advocate
Interview Participant, BCAN Advocate/Patient
Bladder Cancer Patient